Dostarlimab-Gxly 500 mg Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 500 mg
Reference Brands: Jemperli(USA/EU)
Category: Oncology Cancer Care
Dostarlimab is a humanized monoclonal antibody that targets PD‑1 on T cells, blocking its interaction with PD‑L1/PD-L2. This releases the “brake” on the immune system, allowing T cells to attack cancer cells. It is used mainly for mismatch repair–deficient (dMMR) endometrial cancer and certain other solid tumors with dMMR.
Dostarlimab-Gxly — third party manufacturing & bulk supply
Dostarlimab-Gxly 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Dostarlimab-Gxly is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Dostarlimab-Gxly listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Dostarlimab-Gxly →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Dostarlimab-gxly is used for the treatment of certain advanced or recurrent endometrial cancers that are mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H). It helps the immune system recognize and attack cancer cells by blocking the PD-1 receptor.
It is made from a monoclonal antibody that selectively binds to the programmed death-1 (PD-1) receptor on T-cells, preventing tumor cells from evading immune detection.
The trade name is Jemperli.
Jemperli is manufactured by GlaxoSmithKline (GSK).
The generic name is Dostarlimab-gxly.
The brand name is Jemperli.
It is manufactured by GlaxoSmithKline in its approved biologics production facilities for global distribution.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
